PSG announces the results of its extensive research on the latest trends in specialty drug benefits. This exclusive research offers comprehensive insights to assist employers,…
Satisfaction is Shifting The most comprehensive research on PBM customer satisfaction. Overview here was a notable downturn in overall satisfaction levels, as well…
Republished with Permission from AIS Health The FDA recently approved the first novel long-acting granulocyte colony-stimulating factor (G-CSF) in more than 20…
Choosing, negotiating a contract, and navigating a relationship with a pharmacy benefit manager (PBM) isn’t one size fits all. No single PBM is “best” across…
Customer Satisfaction Report Dives into Current PBM Sentiment by Plan Sponsors DALLAS, TX – Pharmaceutical Strategies Group (PSG), an EPIC company, has released its 25th annual…
Much has been written about the sweeping changes contained in the Inflation Reduction Act of 2022 (IRA), including provisions that affect drug pricing. I’ve combed…
Get the Full Analysis of the Big 3 Formulary Changes: 2023 Formulary Changes: CVS Health 2023 Formulary Changes: Express Scripts 2023 Formulary Changes: OptumRx As…
Migraines represent the world’s third most prevalent illness. A new class of drugs called calcitonin gene-related peptide (CGRP) inhibitors entered the market in 2018. Since…
